GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- An RNA-based solution by GreenLight Biosciences designed to protect honeybees from the Varroa destructor mite was named a finalist by Fast Company for its...

Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board BOSTON, March 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC, a biotechnology company focused on RNA research, product design, development, and manufacturing for human, animal, and plant...

GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally Serum Institute of India has engaged GreenLight to design three messenger RNA products, including a vaccine for shingles. Serum Institute of India also has an option to expand the relationship further...

GreenLight agrees to field station in Spain to boost research and development for key plant health projects BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences, a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced its...